News

Applied Clinical Trials Online9h
ODAC Votes Against Risk-Benefit Profile of GSK’s Blenrep Combinations in Relapsed/Refractory Multiple Myeloma
Despite the setback with the Oncologic Drugs Advisory Committee vote, GSK emphasizes the unmet need in multiple myeloma and ...
Applied Clinical Trials Online16h
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world ...
Applied Clinical Trials Online14h
Phase IIIb VOLITION Trial Shows Strong Patient Preference for Long-Acting HIV Therapy After Rapid Suppression on Oral Treatment
New data from the VOLITION study reveal that 89% of treatment-naïve individuals with HIV chose to switch to long-acting cabotegravir and rilpivirine after achieving viral suppression with oral DTG/3TC ...